Regulation of TNF-alpha, IL-1 and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells.
暂无分享,去创建一个
A. Hartmann | D. Männel | K. Resch | G. Lonnemann | R. Hass | N. Topley | M. Goppelt-Strübe | L. Köhler
[1] F. Cozzolino,et al. A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence. , 1990, The EMBO journal.
[2] T. Hirano,et al. Mechanisms of differential regulation of interleukin‐6 mRNA accumulation by tumor necrosis factor alpha and lymphotoxin during monocytic differentiation , 1990, FEBS letters.
[3] A. Hartmann,et al. Differentiation and retrodifferentiation of U937 cells: reversible induction and suppression of intermediate filament protein synthesis. , 1990, European journal of cell biology.
[4] K. Resch,et al. Alterations in glycosylation and lectin pattern during phorbol ester-induced differentiation of U937 cells. , 1990, Cancer research.
[5] W. Vainchenker,et al. Regulation of the expression of IL-6 in human monocytes. , 1989, Journal of immunology.
[6] K. Resch,et al. TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. , 1989, European journal of cell biology.
[7] J. K. Pullen,et al. Regulation of IL-1 and TNF-alpha expression during the differentiation of bone marrow derived macrophage. , 1989, Journal of immunology.
[8] T. Nishida,et al. The transcription of the interleukin 1 beta gene is induced with PMA and inhibited with dexamethasone in U937 cells. , 1988, Biochemical and biophysical research communications.
[9] C. Dinarello,et al. Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. , 1988, Blood.
[10] D. Hazuda,et al. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. , 1988, The Journal of biological chemistry.
[11] K. Resch,et al. Interleukin 1: more than a mediator between leukocytes. , 1988, Trends in pharmacological sciences.
[12] D. Kufe,et al. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. , 1988, The Journal of clinical investigation.
[13] P. Scheurich,et al. Tumor necrosis factor-induced changes of gene expression in U937 cells. Differentiation-dependent plasticity of the responsive state. , 1988, Journal of immunology.
[14] J. Harris,et al. Labelling of lipids and phospholipids with [3H]arachidonic acid and the biosynthesis of eicosanoids in U937 cells differentiated by phorbol ester. , 1988, Biochimica et biophysica acta.
[15] J. Meer,et al. Concentrations of Immunoreactive Human Tumor Necrosis Factor Alpha Produced by Human Mononuclear Cells In Vitro , 1988, Journal of leukocyte biology.
[16] A. Tsou,et al. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. Strom,et al. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. , 1987, Journal of immunology.
[18] H. Holtmann,et al. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. , 1987, Journal of immunology.
[19] R. Rothlein,et al. Membrane-associated interleukin 1 activity on human U937 tumor cells: stimulation of PGE2 production by human chondrosarcoma cells. , 1987, Journal of immunology.
[20] T. Strom,et al. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. , 1986, Journal of immunology.
[21] B. Beutler,et al. Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype , 1986, The Journal of experimental medicine.
[22] R. Philip,et al. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1 , 1986, Nature.
[23] J. Vilček,et al. Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells. , 1986, Archives of biochemistry and biophysics.
[24] E. Unanue,et al. In vivo and in vitro expression of macrophage membrane interleukin 1 in response to soluble and particulate stimuli. , 1986, Journal of immunology.
[25] B. Beutler,et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.
[26] J. Larrick,et al. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. , 1986, Biochemical and biophysical research communications.
[27] B. Beutler,et al. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.
[28] T. Strom,et al. Purification and characterization of a unique human interleukin 1 from the tumor cell line U937. , 1986, Journal of immunology.
[29] S. Kunkel,et al. Prostaglandins as endogenous mediators of interleukin 1 production. , 1986, Journal of immunology.
[30] D. Goeddel,et al. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. , 1985, Journal of immunology.
[31] M. Redinbaugh,et al. Adaptation of the dye-binding protein assay to microtiter plates. , 1985, Analytical biochemistry.
[32] W. Fiers,et al. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. , 1985, Journal of immunology.
[33] J. Oppenheim,et al. Interleukin 1 activity in normal human urine. , 1984, Journal of immunology.
[34] D. Wallach. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. , 1984, Journal of immunology.
[35] M. Cohen,et al. Vitamin D metabolites change the phenotype of monoblastic U937 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[37] E. Unanue,et al. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. , 1982, Journal of immunology.
[38] I. Olsson,et al. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents. , 1982, Cancer research.
[39] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[40] S. Mizel,et al. Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF. , 1979, Journal of immunology.
[41] K. Nilsson,et al. Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.
[42] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[43] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[44] I. Gery,et al. POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.
[45] I. Gery,et al. POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.
[46] W. Crosby,et al. Cytochemical identification of monocytes and granulocytes. , 1971, American journal of clinical pathology.
[47] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[48] D. Nathan,et al. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. , 1968, The New England journal of medicine.
[49] H. Flad,et al. Interleukin 1 and tumor necrosis factor: studies on the induction by lipopolysaccharide partial structures. , 1989, Lymphokine research.
[50] P. Nowell,et al. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. , 1988, The Journal of clinical investigation.
[51] C. Dinarello,et al. A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin. , 1988, Lymphokine research.
[52] J. Meer,et al. A radioimmunoassay for human interleukin-1a: measurement of IL-1a produced in vitro by human blood mononuclear cells stimulated with endotoxin , 1988 .
[53] D. Männel,et al. Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells. , 1987, Lymphokine research.
[54] C. Dinarello,et al. Development and use of a radioimmunoassay for human interleukin-1 beta. , 1987, Lymphokine research.
[55] P. Ralph,et al. Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. , 1985, Cancer research.